Browsing by Author "Ojji, D.B."

Now showing 1 - 4 of 4

May measurement month 2017: screening for hypertension in Nigeria, Sub-Saharan Africa.
(2019) Ogah, O.S.; Arije, A.; Xia, X.; Beaney, T.; Adebiyi, A.A.; Sani, M.U.; Ojji, D.B.; Sogade, T.T.; Izezuo, S.; Chukwuonye, I,I.; Akinwusi, P.; Mbakwem, A.C.; Daniel, F.A.; Omotoso, A.B.; Poulter, N.R.
Pattern of heart failure in Abuja, Nigeria: an echocardiographic
(2009) Ojji, D.B.; Alfa, J.; Ajayi, S.O.; Mamven, M.H.; Falase A.O.
Aim: Despite heart failure having been identified in subjects in sub-Saharan Africa over the last 60 years, there is still a dearth of data, especially echocardiographic data on heart failure. We therefore set out to analyse the clinical and echocardiographic features of all consecutive subjects presenting with heart failure in a tertiary institution in Nigeria. Methods: Three hundred and forty subjects with heart failure, according to the guidelines of the European Society of Cardiology, were studied. Each patient had two-dimensional guided transthoracic echocardiography. Results: The mean age of the patients was 50.60 ± 15.29 years, and 50.9% of the study population were males while 49.1% were females. The commonest cause of heart failure identified was hypertension in 61.5% of the patients; 75.5% had systolic heart failure, whereas 23.5% had heart failure with preserved ejection fraction. Conclusions: Untreated hypertension has been identified as the leading cause of heart failure in Abuja, Nigeria, which is similar to that in many other parts of sub-Saharan Africa. Coronary artery disease is a rare cause of heart failure in this population group.
Prevalence of dyslipidemia in normoglycemic subjects with newly diagnosed high blood pressure in Abuja, Nigeria.
(2009) Ojji, D.B.; Ajayi, S.O.; Manmak, H. M.; Atherthon J.
The H3Africa Consortium (2014). Enabling the Genomic Revolution In Africa. American Association for the Advancement of Science: . 1346-1348pp. ISBN: 1612309842 (United States of America ) (Contribution : 20%) h. Background: High blood pressure and dyslipidemia additively increases the risk of cardiovascular disease. There is a high prevalence of high blood pressure in Nigeria, but there are little data regarding the prevalence of dyslipidemia in subjects with high blood pressure. OBJECTIVE: In this observational prospective study, we examined the prevalence of dyslipidemia in newly diagnosed normoglycemic subjects with high blood pressure. Methods: A total of 171 subjects presenting with high blood pressure for the first time in the cardiology and nephrology clinics at the University of Abuja Teaching Hospital were studied. Height, weight, and blood pressure were measured. Total cholesterol, low-density lipoprotein cholesterol (LDL-C), and high-density lipoprotein cholesterol (HDL-C) were determined in fasting plasma. The total cholesterol/HDL-C and non–HDL-C values were calculated. These measures were then classified according to the 2001 report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. RESULTS: Of the 171 subjects studied, 84 (49%) were male and 87 (51%) were female. Low HDL-C was present in 71 (45.8%), elevated LDL-C in 29 (17%), elevated total cholesterol in 19 (11.1%), and elevated triglyceride in 13 (7.6%), whereas eight (4.7%) of the study population had combined elevated total cholesterol and triglyceride. Female subjects had higher total cholesterol and lower HDL-C than male subjects, but these differences were not statistically significant. Obese subjects, compared to the nonobese, had significantly higher LDL-C and total cholesterol/HDL-C ratios in males and significantly higher triglyceride levels in females. Conclusions: Given the prevalence of dyslipidemia seen in this study, we suggest that fasting lipid measurements should be performed in all Nigerians with high blood pressure. These data suggest the need for health education and lifestyle modifications in hypertensive Nigerians to reduce both types of risk factors.
Risk assessment of adherence in hypertensives and diabetics in a sub-saharan african outpatient clinic.
(2013) Ajayi S.O.; Mamven M.H.; Ojji, D.B.
Medication non adherence is a significant burden to health care utilization[1], in addition to poor disease control. But there is a paucity of structured adherence counselling as a thematic area of care. We have used a modified adherence tool for patients living with HIV and AIDs which incorporates social background, treatment preparation, adherence habits, disclosure of illness, the use of treatment partners, and assessment of potential barriers to adherence. This form was designed only to explore known characteristics that are important for adherence, but patients were asked to make judgement on their own level of adherence. Of the one hundred and eighty one eighty six (47.5%) were males while 95(52.5%) were females. The mean age was 50.83years (SD 12.54). Majority of the patients were married (81.8%) and had at least primary education. Most of the patients whom we interviewed were hypertensives (65%). One hundred and twelve (61.88%) were taking medications during a daily routine, such as eating. Most of the patients, 116(64.10%) had some knowledge about their illness and the medications they were taking by names. Majority of patients (72.4%) had disclosed their illness to their spouses. Many patients self-report that their adherence is good.